153 related articles for article (PubMed ID: 2563893)
1. Effects of ingestion of glucose on GH and TSH secretion: evidence for stimulation of somatostatin release from the hypothalamus by acute hyperglycemia in normal man and its impairment in acromegalic patients.
Shibasaki T; Masuda A; Hotta M; Yamauchi N; Hizuka N; Takano K; Demura H; Shizume K
Life Sci; 1989; 44(6):431-8. PubMed ID: 2563893
[TBL] [Abstract][Full Text] [Related]
2. Effect of a single administration of somatostatin analogue (SMS 201-995) on GH, TSH and insulin secretion in patients with acromegaly.
Horikawa R; Takano K; Hizuka N; Asakawa K; Shibasaki T; Masuda A; Shizume K
Endocrinol Jpn; 1986 Dec; 33(6):743-9. PubMed ID: 2884093
[TBL] [Abstract][Full Text] [Related]
3. The evaluation of hypothalamic somatostatin tone using pyridostigmine and thyrotropin releasing hormone in patients with acromegaly.
Hanew K; Utsumi A; Sugawara A; Shimizu Y; Ikeda H; Abe K
J Endocrinol Invest; 1994 May; 17(5):313-21. PubMed ID: 7915736
[TBL] [Abstract][Full Text] [Related]
4. Serum thyrotropin response to combined arginine and thyrotropin-releasing hormone administration provides evidence for an altered somatostatinergic tone in acromegaly.
Merola B; Colao A; Cataldi M; Rossi E; Longobardi S; Caruso E; Lombardi G
Horm Res; 1992; 37(1-2):7-13. PubMed ID: 1356902
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
Tokuyama T; Yoshinari M; Okamura K; Ikenoue H; Sato K; Kuroda T; Fujishima M
Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):65-74. PubMed ID: 1674920
[TBL] [Abstract][Full Text] [Related]
6. The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly.
Lamberts SW; Zweens M; Klijn JG; van Vroonhoven CC; Stefanko SZ; Del Pozo E
Clin Endocrinol (Oxf); 1986 Aug; 25(2):201-12. PubMed ID: 2878748
[TBL] [Abstract][Full Text] [Related]
7. The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients.
Lamberts SW; Oosterom R; Neufeld M; del Pozo E
J Clin Endocrinol Metab; 1985 Jun; 60(6):1161-5. PubMed ID: 2860119
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin secretion during oral glucose tolerance test in acromegalic patients and control subjects.
Hubina E; Kovács L; Görömbey Z; Szabolcs I; Czirják S; Góth MI
Endocrine; 2003 Nov; 22(2):177-80. PubMed ID: 14665723
[TBL] [Abstract][Full Text] [Related]
9. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin?
Peñalva A; Burguera B; Casabiell X; Tresguerres JA; Dieguez C; Casanueva FF
Neuroendocrinology; 1989 May; 49(5):551-4. PubMed ID: 2566942
[TBL] [Abstract][Full Text] [Related]
10. Long-acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly.
Plewe G; Beyer J; Krause U; Neufeld M; del Pozo E
Lancet; 1984 Oct; 2(8406):782-4. PubMed ID: 6148524
[TBL] [Abstract][Full Text] [Related]
11. The somatostatin analog octreotide inhibits the secretion of growth hormone (GH)-releasing hormone, thyrotropin, and GH in man.
Masuda A; Shibasaki T; Kim YS; Imaki T; Hotta M; Demura H; Ling N; Shizume K
J Clin Endocrinol Metab; 1989 Oct; 69(4):906-9. PubMed ID: 2506217
[TBL] [Abstract][Full Text] [Related]
12. Effect of somatostatin on thyrotropin, prolactin, growth hormone and insulin responses to thyrotropin releasing hormone and arginine in healthy, hypothyroid and acromegalic subjects.
Faure N; Dussault JH; Nadeau A; Szots F; Guyda H; Labrie F
Can Med Assoc J; 1977 Sep; 117(5):478-81. PubMed ID: 409475
[TBL] [Abstract][Full Text] [Related]
13. The effect of calcitonin on growth hormone secretion in acromegaly.
Looij BJ; Roelfsema F; Frölich M
Clin Endocrinol (Oxf); 1989 Nov; 31(5):573-9. PubMed ID: 2627752
[TBL] [Abstract][Full Text] [Related]
14. Suppression of TRH-stimulated TSH secretion by glucose-induced hypothalamic somatostatin release.
Yang I; Woo J; Kim S; Kim J; Kim Y; Choi Y
Horm Metab Res; 1996 Oct; 28(10):553-7. PubMed ID: 8934215
[TBL] [Abstract][Full Text] [Related]
15. Slow release lanreotide treatment in acromegalic patients previously normalized by octreotide.
Morange I; De Boisvilliers F; Chanson P; Lucas B; DeWailly D; Catus F; Thomas F; Jaquet P
J Clin Endocrinol Metab; 1994 Jul; 79(1):145-51. PubMed ID: 8027218
[TBL] [Abstract][Full Text] [Related]
16. Dose-response study of the inhibiting effect of somatostatin on growth hormone and insulin secretion in normal subjects and acromegalic patients.
Giustina G; Peracchi M; Reschini E; Panerai E; Pinto M
Metabolism; 1975 Jul; 24(7):807-15. PubMed ID: 1138156
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of postinhibitory rebound increases in plasma gh in acromegalic patients.
Hanew K; Sasaki A; Sato S; Kasai M; Shimizu Y; Murakami O; Yoshinaga K
Tohoku J Exp Med; 1984 Jan; 142(1):59-65. PubMed ID: 6144195
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
[TBL] [Abstract][Full Text] [Related]
19. Infusion of graded concentrations of somatostatin in man: pharmacokinetics and differential inhibitory effects on pituitary and islet hormones.
Skamene A; Patel YC
Clin Endocrinol (Oxf); 1984 May; 20(5):555-64. PubMed ID: 6146413
[TBL] [Abstract][Full Text] [Related]
20. Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
Quabbe HJ; Plöckinger U
J Clin Endocrinol Metab; 1989 May; 68(5):873-81. PubMed ID: 2565912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
